Abstract
Background: Congenital heart defect (CHD) is the most common type of congenital disorder, especially in the Asian population. However, there are no comprehensive studies assessing the prevalence of this disease in the Iranian population.
Objective: This study aimed to determine the frequency of cardiac abnormalities with a focus on CHD diagnosed by fetal echocardiography in pregnant women. 
Methods: This cross-sectional study utilized the medical records of 635 pregnant women who referred to Imam Reza Hospital in Mashhad, Iran, for fetal echocardiography from 2012 to 2017. All medical records of mothers who referred to a pediatric cardiologist at the CHD center have been assessed in this study. The American Heart Association guideline was used to detect the risk of CHD. Data were analyzed in SPSS version 16.
Results: The mean age of the pregnant women was 29.6±5.13 years and their mean gestational age was 23.5±5.9 weeks. The incidence of fetal cardiac abnormalities was highest in those aged between 26 to 31 years. Fetal cardiac abnormalities were reported in 33.22% of the women. Moreover, the frequency of intra-cardiac echogenic focus was estimated at 25.6% and the frequency values of the complex CHD and ventricular septal defect (VSD) were obtained at 21.76% and 8.05%, respectively. 
Conclusion: According to the obtained results from this study, fetal cardiac abnormalities were found in more than one-third of pregnant women. In addition, the intracardiac echogenic focus was the most common detected cardiac abnormality. The most prevalent detected CHDs were complex CHD and VSD. This indicates a likelihood that the CHD is more common among Asian populations.
 
Keywords: Congenital heart defects, Echocardiography, Pregnant women, Ultrasonography

 

» HTML Fulltext    » PDF Fulltext    » doi: 10.19082/7668

Current Issue

Volume 12, Issue 3, July-September 2020

 


 

The worldwide spread of COVID-19 as an emerging, rapidly evolving situation, and the dramatic need of urgent medicine or vaccine, has rapidly brought new hypotheses for pathophysiology and potential medicinal agents to the fore. It is crucial that the research community provide a way to publish this research in a timely manner.

To contribute to this important public health discussion, the Electronic Physician Journal is excited to announce a fast-track procedure to help researchers publish their articles on COVID-19 related subjects that fall under the broad definition of public health, internal medicine, and pharmacology. We are especially welcome to all hypotheses about the pathological basis of the COVID-19 infection and the possible characteristics of potential medicine and vaccine. Submit your manuscript here


 

The 6th World Conference on Research Integrity (WCRI) is to be held on June 2-5, 2019 in Hong Kong.

The WCRI is the largest and most significant international conference on research integrity. Since the first conference in Lisbon in 2007, it has given researchers, teachers, funding agencies, government officials, journal editors, senior administrators, and research students opportunities to share experiences and to discuss and promote integrity in research. Read more:


 

TDR Clinical Research and Development Fellowships

Call for applications

Deadline for submission: 7 March 2019, 16:00 (GMT)

TDR provides fellowships for early- to mid-career researchers and clinical trial staff (e.g. clinicians, pharmacists, medical statisticians, data managers, other health researchers) in low- and middle-income countries (LMICs) to learn how to conduct clinical trials. Read more:


Meta-Analysis Workshops in New York, USA, and London, UK, in April and May 2019

Don't miss this exceptional opportunity to learn how to perform and report a Meta-analysis correctly. Two Meta-analysis workshops are organized in April and May 2019 by Dr. Michael Borenstein in New York, USA (April 08-10, 2019) and London, UK (May 27-29).

About the Instructor

Dr. Michael Borenstein, one of the authors of Introduction to Meta-Analysis, is widely recognized for his ability to make statistical concepts accessible to researchers as well as to statisticians. He has lectured widely on meta-analysis, including at the NIH, CDC, and FDA. Read more: